Tenecteplase Fails to Boost EVT Outcomes - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

  • By

  • Kathryn Wighton

  • May 14, 2026

  • 6 min

Share

Original Source(s)

Tenecteplase Fails to Boost EVT Outcomes

  • by Kathryn Wighton

  • May 14, 2026

Related Content

Dietary background, serum polyunsaturated fatty acid profiles, and 1-year outcomes after large-artery atherosclerotic stroke: a multicenter cohort study

The progress in predictive modeling of post-stroke epilepsy

Meta-synthesis of fatigue symptom experience and influencing factors in post-stroke fatigue patients in a qualitative study